American Century Companies Inc. Has $1.70 Million Stock Holdings in Bruker Co. (NASDAQ:BRKR)

American Century Companies Inc. raised its holdings in Bruker Co. (NASDAQ:BRKR) by 1.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 28,971 shares of the medical research company’s stock after acquiring an additional 341 shares during the quarter. American Century Companies Inc.’s holdings in Bruker were worth $1,698,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of BRKR. Captrust Financial Advisors acquired a new stake in Bruker in the third quarter valued at approximately $311,000. Jacobs Levy Equity Management Inc. bought a new stake in shares of Bruker in the 3rd quarter worth $313,000. Quantinno Capital Management LP purchased a new stake in shares of Bruker in the third quarter valued at about $268,000. State Street Corp lifted its position in shares of Bruker by 9.6% during the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock valued at $250,501,000 after purchasing an additional 318,808 shares in the last quarter. Finally, National Bank of Canada FI grew its holdings in shares of Bruker by 0.3% in the third quarter. National Bank of Canada FI now owns 94,867 shares of the medical research company’s stock valued at $6,551,000 after acquiring an additional 318 shares in the last quarter. Institutional investors own 79.52% of the company’s stock.

Bruker Stock Up 13.3 %

BRKR stock opened at $41.19 on Thursday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. Bruker Co. has a one year low of $34.10 and a one year high of $90.56. The firm’s fifty day moving average is $46.89 and its 200 day moving average is $55.16. The firm has a market cap of $6.25 billion, a PE ratio of 54.20, a P/E/G ratio of 2.16 and a beta of 1.18.

Bruker (NASDAQ:BRKR) last released its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. On average, research analysts forecast that Bruker Co. will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, March 17th. This represents a $0.20 annualized dividend and a dividend yield of 0.49%. Bruker’s dividend payout ratio is presently 26.32%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on BRKR shares. Stifel Nicolaus decreased their price objective on Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a report on Friday, February 14th. Bank of America increased their price objective on Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Barclays dropped their price objective on Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Citigroup decreased their target price on Bruker from $75.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday. Finally, Guggenheim reaffirmed a “buy” rating on shares of Bruker in a report on Monday, February 24th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $68.00.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.